Bio-Techne (TECH) Interest & Investment Income (2009 - 2026)
Bio-Techne's quarterly Interest & Investment Income came in at $981000.0 in Q1 2026, down 4.39% year-on-year from $1.0 million in Q1 2025, and up 9.36% quarter-over-quarter from $897000.0 in Q4 2025.
Bio-Techne has reported Interest & Investment Income for 18 years, with the latest figure at $981000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 4.39% year-over-year to $981000.0; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (down 18.34% YoY), and the FY2025 full-year result was $3.9 million, up 16.94% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $981000.0, up from $897000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.3 million in Q4 2024, with the low at $168000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $813117.6, with a median of $905000.0 recorded in 2024.
- Year-over-year, Interest & Investment Income soared 479.76% in 2023 and slumped 35.36% in 2025.
- Tracing TECH's Interest & Investment Income over 5 years: stood at $968000.0 in 2022, then retreated by 15.7% to $816000.0 in 2023, then jumped by 65.2% to $1.3 million in 2024, then plunged by 33.46% to $897000.0 in 2025, then climbed by 9.36% to $981000.0 in 2026.
- The last three Interest & Investment Income figures came in at $981000.0 (Q1 2026), $897000.0 (Q4 2025), and $971000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 981,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 981,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | 971,000.00 |
| Jun 30, 2025 | 585,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 926,000.00 |
| Jun 30, 2024 | 905,000.00 |
| Mar 31, 2024 | 712,000.00 |
| Dec 31, 2023 | 816,000.00 |
| Sep 30, 2023 | 890,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 974,000.00 |
| Dec 31, 2022 | 968,000.00 |
| Sep 30, 2022 | 433,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 168,000.00 |
| Dec 31, 2021 | 245,000.00 |
| Sep 30, 2021 | 193,000.00 |
| Jun 30, 2021 | 167,000.00 |
| Mar 31, 2021 | 114,000.00 |
| Dec 31, 2020 | 78,000.00 |
| Sep 30, 2020 | 114,000.00 |
| Jun 30, 2020 | 119,000.00 |
| Mar 31, 2020 | 144,000.00 |
| Dec 31, 2019 | 231,000.00 |
| Sep 30, 2019 | 111,000.00 |
| Jun 30, 2019 | 270,000.00 |
| Mar 31, 2019 | 84,000.00 |
| Dec 31, 2018 | 114,000.00 |
| Sep 30, 2018 | 102,000.00 |
| Jun 30, 2018 | 102,000.00 |
| Mar 31, 2018 | 162,000.00 |
| Dec 31, 2017 | 68,000.00 |
| Sep 30, 2017 | 76,000.00 |
| Jun 30, 2017 | 93,000.00 |
| Mar 31, 2017 | 73,000.00 |
| Dec 31, 2016 | 89,000.00 |
| Sep 30, 2016 | 49,000.00 |
| Jun 30, 2016 | 57,000.00 |
| Mar 31, 2016 | 65,000.00 |
| Dec 31, 2015 | 51,000.00 |
| Sep 30, 2015 | 61,000.00 |
| Jun 30, 2015 | 127,000.00 |
| Mar 31, 2015 | 158,000.00 |
| Dec 31, 2014 | 171,000.00 |
| Sep 30, 2014 | 185,000.00 |
| Jun 30, 2014 | 1.04 Mn |
| Mar 31, 2014 | 529,000.00 |
| Dec 31, 2013 | 545,000.00 |
| Sep 30, 2013 | 567,000.00 |
| Jun 30, 2013 | 670,000.00 |
| Mar 31, 2013 | 638,000.00 |
| Dec 31, 2012 | 677,000.00 |
| Sep 30, 2012 | 661,000.00 |
| Jun 30, 2012 | 643,000.00 |
| Mar 31, 2012 | 470,000.00 |
| Dec 31, 2011 | 798,000.00 |
| Sep 30, 2011 | 728,000.00 |
| Jun 30, 2011 | 818,000.00 |
| Mar 31, 2011 | 1.07 Mn |
| Dec 31, 2010 | 1.02 Mn |
| Sep 30, 2010 | 847,000.00 |
| Jun 30, 2010 | 1.01 Mn |
| Mar 31, 2010 | 1.04 Mn |
| Dec 31, 2009 | 1.16 Mn |
| Sep 30, 2009 | 1.17 Mn |